Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

Biogen is investing $2 billion in its U.S. manufacturing footprint — but not in Massachusetts, where the drug company is ...

AdFalciVax may offer advantages such as broader protection and a lower risk of immune evasion compared to existing ...

Operations have begun at an Abu Dhabi vaccine distribution hub primed to deliver millions of doses each year as part of a mission to improve access to health care across the region. The logistics ...

Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) jumped 3.4% in the morning session as investors ...

"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...

Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DoH, Abu ...

iTeos Therapeutics has agreed to be acquired by privately held Concentra Biosciences in a deal initially worth roughly $385 million. iTeos on Monday said Concentra will pay nearly $10.05 a share in ...

Abu Dhabi's vaccine distribution hub, developed in partnership with stakeholders including Etihad Cargo, has begun operations ...

A strategic milestone for the capital to strengthen global health security, ensure equitable vaccine access and build resilient supply chains ...